HSTM Stock Analysis: Buy, Sell, or Hold?
HSTM - HealthStream Inc
$28.04
-0.16 (-0.57%)
▼
5d:
+3.34%
30d:
-0.85%
90d:
+35.07%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 03, 2026
TODAY
Get Alerted When HSTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: HSTM shows positive signals but monitor for confirmation. Market pricing in 5.8% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: HSTM shows positive signals but monitor for confirmation. Market pricing in 5.8% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.44
Based on 7.1% avg growth
INTRINSIC VALUE TODAY
$18.90
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HSTM is currently trading at $28.04, which is considered fair relative to its 30-day fair value range of $26.98 to $28.82. From a valuation perspective, the stock is trading at a premium (Forward PE: 32.4) compared to its historical average (27.4). At these levels, the market is pricing in 5.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HSTM is in a strong uptrend. Immediate support is located at $26.26, while resistance sits at $29.68.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $33.50 (+19.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HSTM is in a strong uptrend. Immediate support is located at $26.26, while resistance sits at $29.68.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $33.50 (+19.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$26.98 -
$28.82
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($33.50)
- NEUTRAL: Trading at premium valuation - market expects 5.8% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$26.98 -
$28.82
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$26.26
Resistance Level
$29.68
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
32.42
Wall Street Target
$33.50
(+19.5%)
Revenue Growth (YoY)
10.5%
Earnings Growth (YoY)
42.9%
Profit Margin
6.4%
Valuation Premium vs History
+5.8% premium
PE vs Historical
32.4 vs 27.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.8%
(market-implied from PE analysis)
1-Year Target
$29.67
(+6%)
2-Year Target
$31.39
(+12%)
3-Year Target
$33.21
(+18%)
3-Yr Target (if PE normalizes)
(PE: 32→27)
PE COMPRESSION
$28.07
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 32.4, Growth: 10.2%)
$37.52
(+34%)
Base:
(SPY PE: 20.7, Growth: 10.2%)
$23.99
(-14%)
Bear:
(PE: 17.6, Growth: 10.2%)
$20.39
(-27%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (44x PE), but valuation improves significantly next year (32x PE) as earnings recover.
Trailing PE: 44.06 | Current EPS (TTM): $0.64
Bull Case
$41.93
(+50%)
Analyst growth 35.2%, PE expands to 48.5
Base Case
$38.11
(+36%)
Market implied 35.2%, PE stable at 44.1
Bear Case
$19.18
(-32%)
Severe decline -20.0%, PE contracts to 37.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 2:47 PM ET
Data refreshes hourly during market hours. Next update: 3:47 PM
Data refreshes hourly during market hours. Next update: 3:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$244 | 55 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 59 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 53 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 49 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 50 HOLD |
